Blood test to predict female infertility
Part of Women’s health & pregnancy clinical trials.
This trial looks for a blood test that could help predict infertility in women. If you are between 18 and 43, struggling with infertility or recurrent pregnancy loss, this study may be a fit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 43 years old.
- You are currently going through fertility treatments like IVF or have had repeated miscarriages.
- You have not had surgery on your ovaries before.
- Your partner does not have a severe male factor infertility issue.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial creates a biobank of samples from people with gynecological issues, infertility, or pregnancy problems. It aims to help researchers better understand these conditions and develop future treatments.
This study tests whether a simple blood test taken before embryo transfer can help predict if the embryo will implant successfully. It is designed for women who have had unexplained repeated implantation failure and are planning another IVF cycle with frozen embryos.
This study measures changes in your blood immune markers during frozen embryo transfer when the embryo is chromosomally normal. It may help clinics understand what blood immune patterns relate to successful pregnancy in natural or hormone-prepared cycles.
This study looks at immune-related blood patterns and other measurements to better understand why some women have repeated pregnancy loss or repeated IVF implantation failure. If you qualify, your answers and test results may help researchers identify biomarkers that could guide future care.
This study looks at “biomarkers” (test signals in your blood or cycle data) to better judge how ready the womb lining is during IVF. It compares two types of IVF hormone setups to see which approach best matches endometrial receptivity and supports successful embryo transfer.
This study looks at whether a blood progesterone level around the time of a pregnancy test during fertility treatment helps predict which patients will have an ongoing pregnancy. It may help doctors better understand who is most likely to continue developing a pregnancy during artificial cycles.
Hear when a new Female Infertility trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.